ES2163144T3 - Nuevos analogos de vitamina d. - Google Patents

Nuevos analogos de vitamina d.

Info

Publication number
ES2163144T3
ES2163144T3 ES97917272T ES97917272T ES2163144T3 ES 2163144 T3 ES2163144 T3 ES 2163144T3 ES 97917272 T ES97917272 T ES 97917272T ES 97917272 T ES97917272 T ES 97917272T ES 2163144 T3 ES2163144 T3 ES 2163144T3
Authority
ES
Spain
Prior art keywords
vitamin
new analogs
compounds
indeseable
hydrocarbilic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97917272T
Other languages
English (en)
Inventor
Gunnar Grue-Sorensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Application granted granted Critical
Publication of ES2163144T3 publication Critical patent/ES2163144T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE FORMULA (I), EN LA CUAL Q REPRESENTA UN DIRRADICAL HIDROCARBILENO C1-C8 , R REPRESENTA HIDROGENO O HIDROCARBILO C1-C6 , O DOS GRUPOS R, CONJUNTAMENTE CON EL ATOMO DE CARBONO QUE LLEVA EL GRUPO OH, PUEDEN FORMAR UN CICLO CARBOCICLICO C3-C8. DICHOS COMPUESTOS MUESTRAN EFECTOS INMUNOMO DULADORES Y ANTIINFLAMATORIOS, ASI COMO UNA FUERTE ACTIVIDAD EN LA DIFERENCIACION E INHIBICION DE LA PROLIFERACION INDESEABLE DE CIERTAS CELULAS.
ES97917272T 1996-04-03 1997-03-21 Nuevos analogos de vitamina d. Expired - Lifetime ES2163144T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9607034.7A GB9607034D0 (en) 1996-04-03 1996-04-03 Chemical compounds

Publications (1)

Publication Number Publication Date
ES2163144T3 true ES2163144T3 (es) 2002-01-16

Family

ID=10791549

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97917272T Expired - Lifetime ES2163144T3 (es) 1996-04-03 1997-03-21 Nuevos analogos de vitamina d.

Country Status (19)

Country Link
US (1) US5932565A (es)
EP (1) EP0891326B1 (es)
JP (1) JP2000508635A (es)
KR (1) KR100478741B1 (es)
CN (1) CN1075809C (es)
AT (1) ATE206394T1 (es)
AU (1) AU713630B2 (es)
CZ (1) CZ290097B6 (es)
DE (1) DE69707121T2 (es)
DK (1) DK0891326T3 (es)
ES (1) ES2163144T3 (es)
GB (1) GB9607034D0 (es)
HU (1) HUP9901600A3 (es)
NZ (1) NZ329531A (es)
PL (1) PL186771B1 (es)
PT (1) PT891326E (es)
RO (1) RO118286B1 (es)
RU (1) RU2169142C2 (es)
WO (1) WO1997037972A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001030751A2 (en) * 1999-10-25 2001-05-03 Strakan Limited USES OF 1,25-DIHYDROXY-5,6-trans VITAMIN D COMPOUNDS AND DERIVATIVES THEREOF
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US6753435B1 (en) 2000-03-30 2004-06-22 Teijin Limited Intermediates for vitamin D and processes for the preparation thereof
AUPR731901A0 (en) * 2001-08-28 2001-09-20 Goodchild, Colin Stanley Method of treatment
CA2586679A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
CA2981549A1 (en) 2009-01-27 2010-08-05 Berg Llc Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
CN106265695B (zh) 2009-08-14 2021-05-07 博格有限责任公司 用于治疗脱发的维生素d3及其类似物
CN112156097A (zh) 2013-05-29 2021-01-01 博格有限责任公司 使用维生素d预防或减轻化疗诱发的脱发

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE143007T1 (de) * 1991-07-05 1996-10-15 Duphar Int Res Vitamin-d derivat, verfahren zu dessen herstellung sowie zwischenprodukte dafür
JP3493037B2 (ja) * 1991-12-18 2004-02-03 中外製薬株式会社 ２２−オキサコレカルシフェロール誘導体とその製造方法

Also Published As

Publication number Publication date
GB9607034D0 (en) 1996-06-05
DE69707121T2 (de) 2002-07-11
CN1196720A (zh) 1998-10-21
PL186771B1 (pl) 2004-02-27
AU713630B2 (en) 1999-12-09
RU2169142C2 (ru) 2001-06-20
JP2000508635A (ja) 2000-07-11
CZ290097B6 (cs) 2002-05-15
EP0891326A1 (en) 1999-01-20
CN1075809C (zh) 2001-12-05
WO1997037972A1 (en) 1997-10-16
KR19990035844A (ko) 1999-05-25
AU2567097A (en) 1997-10-29
CZ898A3 (cs) 1998-06-17
HUP9901600A3 (en) 1999-11-29
KR100478741B1 (ko) 2005-07-07
ATE206394T1 (de) 2001-10-15
US5932565A (en) 1999-08-03
HUP9901600A2 (hu) 1999-09-28
PL324635A1 (en) 1998-06-08
DE69707121D1 (de) 2001-11-08
EP0891326B1 (en) 2001-10-04
DK0891326T3 (da) 2002-01-28
PT891326E (pt) 2002-03-28
NZ329531A (en) 2001-03-30
RO118286B1 (ro) 2003-04-30

Similar Documents

Publication Publication Date Title
ES2101319T3 (es) Analogos de la vitamina d.
BR0312037A (pt) Oxidação de compostos orgânicos
ES2098031T3 (es) Nuevos analogos de vitamina d.
ES2117281T3 (es) Nuevos analogos de la vitamina d.
AR011116A1 (es) Compuesto derivado de n-hidroxi-beta-sulfonil propionamida y composicion farmaceutica que lo contiene
ES2098123T3 (es) Nuevos analogos de vitamina d.
AR025739A1 (es) Nuevos derivados de bencimidazolonas que tienen afinidad para receptores mezclados de serotonina y dopamina
HN1998000143A (es) Tetrahidronaftalenos substituidos y compuestos analogos.
BRPI0507968A (pt) oxidação de compostos orgánicos a ph alto
ES2139943T3 (es) Nuevos inhibidores de la sintasa de prostaglandina.
YU49389B (sh) Postupak odorisanja gasa
ES2193874B1 (es) Compuestos naturales y derivados de estos para la prevencion y el tratamiento de enfermedades cardiovasculares, hepaticas, renales y cosmeticas.
BR9912073A (pt) Composições farmacêuticas que compreendem 2-quinolonas
PT1017659E (pt) Tetra-hidronaftalenos substituidos e compostos analogos
ES2171022T3 (es) Esteres de etilenglicol de derivados de monohidrobenzoporfirinas como agentes fotoactivos.
ES2114619T3 (es) Nuevos analogos de la vitamina d.
BR9914163A (pt) Agente para melhorar a potência excretora da bexiga urinária, uso de um composto de amina do tipo não carbamato que tenha uma ação inibidora de acetilcolinesterase, e, método para melhorar a potência excretora da bexiga urinária
ES2163144T3 (es) Nuevos analogos de vitamina d.
ES2101073T3 (es) Nuevos aza-androstano-derivados 17-beta-substituidos.
GT199900081A (es) Compuestos de sulfonilbenceno como agentes anti-inflamatorios / analgesicos.
ES2062758T3 (es) Nuevos analogos de vitamina d.
ES2164366T3 (es) Derivados de la distamicina acriloil sustituidos, procedimiento de fabricacion asociado y su utilizacion como agentes antitumorales y antivirales.
BR0110087A (pt) Compostos para modular proliferação celular
ES2084792T3 (es) Derivados de hexahidroazepinas, un procedimiento para su preparacion y composiciones.
ES2169073T3 (es) Composiciones en forma de soluciones solidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 891326

Country of ref document: ES